Jeanette Mucha
CEO, Chief Science Officer and Co-Founder

Jeanette is a microbiologist and immunologist with over fourteen years experience. She is a prolific inventor who holds patents in the areas of microbial strain selection and immunology, as well as numerous provisional patents and trade secrets. She has a BS in Biology from the University of Miami. Jeanette is also a 18 time Ironman distance triathlon finisher, including the 2009 World Championship.

Anthony Cann, PhD
Chief Technology Officer and Co-Founder

Dr. Cann has over thirteen years of experience in strain improvement with expertise in microbial metabolism. Anthony has conducted several successful technology transfers around the globe, from test tube to large scale fermentations. He earned a PhD in Chemical Engineering from UCLA, a BS in Chemical Engineering from Rose-Hulman Institute of Technology, and he co-authored several patent applications in the fields of strain development and biochemical production.


Derik Twomey
Chief Operations Officer and Co-Founder

Derik is a microbiologist and fermentation specialist with over eight years industrial experience. He is very versatile in the multidisciplinary environment of a startup; having contributed to biomass pre-treatment, microbiology, and scale-up fermentation R&D areas within the cleantech industry. Derik holds a BS in Cell & Developmental Biology from the University of California at Santa Barbara.

Maya Kuttan, Esq. 
Chief Counsel and Media Specialist

Maya has over eight years of experience as an attorney and eleven years as a media specialist. She has provided regulatory counseling, enforcement, litigation support and rulemaking for the U.S. Environmental Protection Agency and municipalities, agencies, and nonprofits. She earned a JD from the University of California, Los Angeles (UCLA) School of Law and a BA from the University of Southern California’s School of Cinematic Arts. Maya has garnered awards for her films and legal work.


Stacy Townsend, PhD
Director of Pre-Clinical Development

Dr. Townsend has over 15 years of research and preclinical development experience with expertise in host-pathogen interactions supporting biotechnology with a broad range of therapeutic indications. Stacy has successfully led R&D efforts resulting in numerous patents, grants, and IND submissions. She earned her Ph.D. in Veterinary Microbiology from Texas A&M University, a BS from the University of California, Riverside.


Gregory R. Govoni, PhD
Director of Pre-Clinical Research

Dr. Govoni has close to 20 years of experience in the microbiology and immunology fields with 5 years as a project lead at a local Bay Area startup developing novel anti-bacterial agents. He earned his PhD degree in Biochemistry from McGill University and completed a post-doctoral fellowship in Microbiology and Immunology with Dr. Stanley Falkow at Stanford University. He has co-authored 20 peer-reviewed scientific publications as well as been named co-inventor on multiple patents.

Advisory Board

Dr. Julian Davies, PhD

The pioneer of metagenomics, 60 yrs in microbiology, infectious disease expert. Professor Emeritus at Life Sciences Institute at the University of British Columbia.

Dr. Peter Dürre, PhD

A leading expert in Clostridium difficile and gene transfer technology. Head of Microbiology and Biotechnology Departments at Ulm University.

Dr. Annalisa Jenkins, MRCP, FRCP

20yrs industry experience, CEO Dimension Therapeutics, former head of Global Research and Development for Merck Serono.

Dr. Mark Wilcox, MD

Lead on Clostridium difficile for the Public Health England, he's an expert on Antimicrobial Resistance and Infection Control. Head of Microbiology and Pathology at the University of Leeds.